EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 3.0

Postoperative therapy for local-advanced gastric cancer: A systematic review and meta-analysis

Zhuo Wang, Lihua Dong, Weiyan Shi, Ling Gao, Xin Jiang, Suyang Xue, Pengyu Chang

Advances in Clinical and Experimental Medicine · 2023

DOI: 10.17219/acem/171616 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Zhuo Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Adjuvant therapy after surgery is effective for the treatment of advanced gastric cancer (GC), but the regimens are not uniform, resulting in imbalanced benefits. OBJECTIVES: To compare the overall survival (OS), relapse-free survival (RFS) and disease-free survival (DFS) of patients with local-advanced GC (LAGC) after surgery plus adjuvant therapy and with surgery alone based on meta-analysis. MATERIAL AND METHODS: Literature search was performed among the articles published in the PubMed, Embase and Cochrane Library databases from January 2000 to December 2018. Study selection was conducted based on the following criteria: randomized clinical trials (RCTs) on surgery plus adjuvant therapy compared to surgery alone; studies compared OS and/or RFS/DFS; and cases medically confirmed with LAGC. Only articles in English were included. RESULTS: A total of 12 datasets from 11 randomized controlled trials (RCTs) involving 4606 patients were included in the meta-analysis. There was a significant improvement in OS of patients who underwent postoperative adjuvant therapy (HR 0.78; 95% CI: 0.72-0.84; p < 0.001). In the subgroup analysis, it showed a higher improvement in OS patients who received adjuvant chemotherapy plus immunotherapy or radiotherapy (HR 0.72; 95% CI: 0.61-0.85; p < 0.001). CONCLUSION: Adjuvant therapy led to survival benefits in patients with LAGC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHumansChemotherapy, AdjuvantRandomized Controlled Trials as TopicDisease-Free SurvivalRadiotherapy, AdjuvantCombined Modality TherapyTreatment OutcomeGastrectomy

Stichwörter der Autor:innen

chemotherapygastric canceroverall survivalradiotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China.
  • Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, China.

Zitieren

APA

Wang, Z., Dong, L., Shi, W., Gao, L., Jiang, X., Xue, S., & Chang, P. (2023). Postoperative therapy for local-advanced gastric cancer: A systematic review and meta-analysis. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/171616

Vancouver

Wang Z, Dong L, Shi W, Gao L, Jiang X, Xue S, et al. Postoperative therapy for local-advanced gastric cancer: A systematic review and meta-analysis. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/171616

BibTeX
@article{Wang2023,
  author = {Wang, Zhuo and Dong, Lihua and Shi, Weiyan and Gao, Ling and Jiang, Xin and Xue, Suyang and Chang, Pengyu},
  title = {Postoperative therapy for local-advanced gastric cancer: A systematic review and meta-analysis},
  journal = {Advances in Clinical and Experimental Medicine},
  year = {2023},
  doi = {10.17219/acem/171616}
}
Kostenlos starten →